Company news
Oxford BioDynamics PLC news in 2026
Oxford BioDynamics PLC's news releases, calls and decks from 2026, newest first.
First pharma agreement for EpiSwitch Orion
November 5, 2026
Delayed Settlement Resolved
November 3, 2026
Extension of Timetable in relation to Placing
October 1, 2026
Orion reveals link between five fatigue conditions
September 3, 2026
Partnership with Dubai London Clinics & Hospitals
August 13, 2026
First commercial agreement for EpiSwitch® Orion
July 28, 2026
US contract sales partnership
June 30, 2026
Board Appointment
April 15, 2026
OBD to present at PMWC 2026
March 3, 2026
Change of Nominated Adviser
February 17, 2026
Holding(s) in Company
January 27, 2026
Result of AGM
January 26, 2026
Board Change
January 26, 2026
Pilot Study Finds 30-Day Molecular Improvement in Prostate Health Following Intraprostatic Ozone Therapy, Tracked by the EpiSwitch® PSE Blood Test
January 22, 2026